Page 63 - GPD-1-2

Gene & Protein in Disease circRNAs and cancer

cells through regulating miRNA-338-3p. Onco Targets Ther, 109. Zhang H, Wang G, Ding C, et al., 2017, Increased circular
12: 3363–3372. RNA UBAP2 acts as a sponge of miR-143 to promote
osteosarcoma progression. Oncotarget, 8(37): 61687–61697.
https://doi.org/10.2147/OTT.S196931
https://doi.org/10.18632/oncotarget.18671
99. Wang X, Wang R, Wu Z, et al., 2019, Circular RNA ITCH
suppressed prostate cancer progression by increasing 110. Xiong Y, Zhang J, Song C, 2018, CircRNA ZNF609 functions
HOXB13 expression via spongy miR-17-5p. Cancer Cell Int, as a competitive endogenous RNA to regulate FOXP4
19: 328. expression by sponging miR-138-5p in renal carcinoma.
J Cell Physiol, 234(7): 10646–10654.
https://doi.org/10.1186/s12935-019-0994-8
https://doi.org/10.1002/jcp.27744
100. Szymczyk A, Macheta A, Podhorecka M, 2018, Abnormal
microRNA expression in the course of hematological 111. Chen L, Zhang S, Wu J, et al., 2019, circRNA_100290 plays a
malignancies. Cancer Manag Res, 10: 4267–4277. role in oral cancer by functioning as a sponge of the miR-29
family. Oncogene, 36(32): 4551–4561.
https://doi.org/10.2147/CMAR.S174476
https://doi.org/10.1038/onc.2017.89
101. Li W, Zhong C, Jiao J, et al., 2017, Characterization of hsa_
circ_0004277 as a new biomarker for acute myeloid leukemia 112. De Rubis G, Krishnan SR, Bebawy M, 2019, Liquid biopsies
via circular RNA profile and bioinformatics analysis. Int J in cancer diagnosis, monitoring, and prognosis. Trends
Mol Sci, 18(3): 597. Pharmacol Sci, 40(3): 172–186.
https://doi.org/10.3390/ijms18030597 https://doi.org/10.1016/j.tips.2019.01.006
102. L’Abbate A, Tolomeo D, Cifola I, et al., 2018, MYC-containing 113. Kwapisz D, 2017, The first liquid biopsy test approved. Is it a
amplicons in acute myeloid leukemia: Genomic structures, new era of mutation testing for non-small cell lung cancer?
evolution, and transcriptional consequences. Leukemia, Ann Transl Med, 5(3): 46.
32(10): 2152–2166.
https://doi.org/10.21037/atm.2017.01.32
https://doi.org/10.1038/s41375-018-0033-0
114. Zaporozhchenko IA, Ponomaryova AA, Rykova EY, et al.,
103. Liu J, Kong F, Lou S, et al., 2018, Global identification of 2018, The potential of circulating cell-free RNA as a cancer
circular RNAs in chronic myeloid leukemia reveals hsa_ biomarker: Challenges and opportunities. Expert Rev Mol
circ_0080145 regulates cell proliferation by sponging miR- Diagn, 18(2): 133–145.
29b. Biochem Biophys Res Commun, 504(4): 660–665.
https://doi.org/10.1080/14737159.2018.1425143
https://doi.org/10.1016/j.bbrc.2018.08.154
115. Lamb YN, Dhillon S, (2017), Epi proColon® 2.0 CE: A blood-
104. Xia L, Wu L, Bao J, et al., 2018, Circular RNA circ-CBFB based screening test for colorectal cancer. Mol Diagn Ther,
promotes proliferation and inhibits apoptosis in chronic 21(2): 225–232.
lymphocytic leukemia through regulating miR-607/FZD3/ https://doi.org/10.1007/s40291-017-0259-y
Wnt/β-catenin pathway. Biochem Biophys Res Commun,
503(1): 385–390. 116. Baassiri A, Nassar F, Mukherji D, et al., 2020, Exosomal non
coding RNA in LIQUID biopsies as a promising biomarker
https://doi.org/10.1016/j.bbrc.2018.06.045
for colorectal cancer. Int J Mol Sci, 21(4): 1398.
105. Dahl M, Daugaard I, Andersen MS, et al., 2018, Enzyme-
free digital counting of endogenous circular RNA molecules https://doi.org/10.3390/ijms21041398
in B-cell malignancies. Lab Invest, 98(12): 1657–1669. 117. He AT, Liu J, Li F, et al., 2021, Targeting circular RNAs as
a therapeutic approach: Current strategies and challenges.
https://doi.org/10.1038/s41374-018-0108-6
Signal Transduct Target Ther, 6(1): 185.
106. Mei M, Wang Y, Li Z, et al., 2019, Role of circular RNA in
hematological malignancies. Oncol Lett, 18(5): 4385–4392. https://doi.org/10.1038/s41392-021-00569-5
118. Wen G, Zhou T, Gu W, 2020, The potential of using blood
https://doi.org/10.3892/ol.2019.10836
circular RNA as liquid biopsy biomarker for human diseases.
107. Zhong Z, Lv M, Chen J, 2016, Screening differential Protein Cell, 12(12): 911–946.
circular RNA expression profiles reveals the regulatory
role of circTCF25-miR-103a-3p/miR-107-CDK6 pathway https://doi.org/10.1007/s13238-020-00799-3
in bladder carcinoma. Sci Rep, 6: 30919. 119. Nsengimana B, Khan FA, Ngowi EE, et al., 2022, Processing
body (P-body) and its mediators in cancer. Mol Cell Biochem,
https://doi.org/10.1038/srep30919
477(4): 1217–1238.
108. Li P, Liu H, Wang Z, et al., 2016, MicroRNAs in laryngeal
cancer: Implications for diagnosis, prognosis and therapy. https://doi.org/10.1007/s11010-022-04359-7
Am J Transl Res, 8(5): 1935–1944. 120. Lampis, A. Ghidini, M. Ratti, et al., 2020, Circulating

Volume 1 Issue 2 (2022) 16 https://doi.org/10.36922/gpd.v1i2.138